Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions

Medicina Clinica

Volumn 133, Issue 12, 2009, Pages 449-453

  Alemán, Carmen ^a   Manuel Porcel, José ^b   Ma Segura, Rosa ^a   Alegre, José ^a   Esquerda, Aureli ^b   Ruiz, Eva ^a   Bielsa, Silvia ^b   De Sevilla, Tomás Fernández ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

Mesothelin; MM; Pleural effusion

Indexed keywords

MESOTHELIN; SOLUBLE MESOTHELIN RELATED PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; IDIOPATHIC DISEASE; INFECTION; MAJOR CLINICAL STUDY; MESOTHELIOMA; METASTASIS; PLEURA EFFUSION; PLEURA FLUID;

ADENOCARCINOMA; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CARCINOMA, SMALL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MESOTHELIOMA; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 70349617907     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.11.047     Document Type: Article

References (39)

1. A. Scherpereel Guidelines of the French Speaking Society for Chest Medicine for management of MM Respir Med 101 2007 1265 1276
2. A.M. Boylan Mesothelioma: new concepts in diagnosis and management Curr Opin Pulm Med 6 2000 157 163 (Pubitemid 30701544)
3. C. Alemán, Ll. Sanchez, J. Alegre, E. Ruiz, A. Vázquez, and T. Soriano Differentiation between malignant and idiopathic pleural effusions. The value of diagnostic procedures Q J Med 100 2007 351 359 (Pubitemid 47073811)
4. J.S. Ferrer, X.G. Muñoz, R.M. Orriols, R.W. Light, and F.B. Morell Evolution of Idiopathic Pleural Effusion Chest 109 1996 1508 1513
5. J.M. Porcel, M. Vives, A. Esquerda, A. Salud, B. Perez, and F. Rodríguez-Panadero Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions Chest 126 2004 1757 1763 (Pubitemid 39643976)
6. D. Shitrit, B. Zingerman, A.B. Shitrit, D. Shlomi, and M.R. Kramer Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature Oncologist 10 2005 501 507 (Pubitemid 41266331)
7. V. Villena, A. Lopez-Encuentra, J. Echave-Sustaeta, P. Martín-Escribano, B. Ortuño-de-Solo, and J. Estenoz-Alfaro Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4 Lung Cancer 40 2003 289 294 (Pubitemid 36627708)
8. M. Miedouge, P. Rouzaud, G. Salama, M.C. Pujazon, C. Vincent, and M.A. Mauduyt Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions Br J Cancer 81 1999 1059 1065 (Pubitemid 29516152)
9. F. Alatas, O. Alatas, M. Metintas, O. Colak, E. Harmanci, and S. Demir Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions Lung Cancer 31 2001 9 16 (Pubitemid 32012598)
10. M. Haro, M.T. Casamitjá, L.A. Alvárez, J.C. Calderón, S. Martínez, and F. Sebastián Importancia de la determinación de la amilasa pleural en los pacientes con derrame pleural neoplásico Med Clin (BARC) 129 2007 372 374
11. J. Mezger, A. Calavrezos, P. Drings, U. Gatzemeier, E. Kaukel, and N. Konietzko Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases Lung 172 1994 183 184 (Pubitemid 24287304)
12. C. Fuhrman, J.C. Duche, C. Chouaid, I. Abd Alsamad, K. Atassi, and I. Monnet Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies Clin Biochem 33 2000 405 410 (Pubitemid 30767468)
13. B. Robinson, and R. Lake Advances in malignant mesothelioma N Engl J Med 353 2005 1591 1603 (Pubitemid 41434638)
14. R. Bast Status of tumor markers in ovarian cancer screening J Clin Oncol 21 2003 200s 205s
15. P. Argani, C. Iacobuzio-Donahue, B. Ryu, C. Rosty, M. Goggins, and R. Wilentz et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE) Clin Cancer Res 7 2001 3862 3868
16. D. Fan, S. Yano, H. Shinohara, C. Solorzano, M. Van Arsdall, and C. Bucana et al. Targeted therapy against human lung cancer in nude mic by high-affinity recombinant antimesothelin single-chain Fv immunotoxin Mol Cancer Ther 1 2002 595 600
17. N. Scholler, N. Fu, Y. Yang, Z. Ye, G. Goodman, and K. Hellstrom Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma Propc Natl Acad Sci 96 1999 11531 11536 (Pubitemid 29487415)
18. N. Ordoñez Application of mesothelin immunostaining in tumor diagnosis Am J Surg Pathol 27 2003 1418 1428 (Pubitemid 37315193)
19. R. Pu, Y. Pang, and C. Michael Utility of WT-1, p63, MOC31, Mesothelin and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma and malignant mesothelioma in effusions Diagn Cytopathol 36 2008 20 25
20. C. Kachali, I. Eltoum, D. Horton, and D.C. Chhieng Use of mesothelin as a marker for mesothelial cells in cytologic specimens Semin Diagn Pathol 23 2006 20 24 (Pubitemid 44415394)
21. B. Robinson, J. Creaney, R. Lake, A. Nowark, A. William, and N. de Klerk Soluble mesothelin-related protein-A blood test for mesothelioma Lung Cancer 4951 2005 5109 5111 (Pubitemid 40798859)
22. J. Creaney, and B. Robinson Detection of malignant mesothelioma in asbestos-exposed individuals: The potential role of soluble mesothelin-related protein Hematol Oncol Clin North Am 19 2005 1025 1040 (Pubitemid 41736040)
23. M. Ho, R. Hassan, J. Zhang, Q. Wang, M. Onda, and T. Bera Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients Clin Cancer Res 2005 2005 3814 3820 (Pubitemid 40685601)
24. H. Beyer, R. Geschwindt, C. Glover, L. Tran, I. Hellstrom, and K. Hellstrom Mesomark™: A potential test for malignant pleural mesothelioma Clin Chem 53 2007 666 672 (Pubitemid 46580236)
25. J. Creaney, I. Van Bruggen, M. Hof, A. Segal, A. Musk, and N. de Klerk Combined CA 125 and mesothelin levels for the diagnosis of malignant mesothelioma Chest 132 2007 1239 1246 (Pubitemid 47620999)
26. B. Robinson, J. Creaney, R. Lake, A. Noeak, A. Musk, and N. de Klerk et al. Mesothelin-family protein and diagnosis of mesothelioma Lancet 362 2003 1612 1616
27. A. Cristaudo, R. Foddis, A. Vivaldi, G. Guglielmi, N. Dipalma, and R. Filiberti Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer Clin Cancer Res 13 2007 5076 5081 (Pubitemid 47502073)
28. B.D. Grigoriu, A. Scherpereel, P. Devos, B. Chachine, M. Letourneux, and P. Lebailly Utility of osteopontine and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment Clin Cancer Res 13 2007 2928 2935 (Pubitemid 46850705)
29. H.I. Pass, A. Wali, N. Tang, A. Ivanova, S. Ivanov, and M. Harbut Soluble mesothelin-related peptide level evaluation in mesothelioma serum and pleural effusions Ann Thorac Surg 85 2008 265 272 (Pubitemid 350265805)
30. A. Scherpereel, B. Grigoriu, M. Conti, T. Gey, M. Gregoire, and M.C. Copin Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma Am J Respir Crit Care Med 173 2006 1155 1160 (Pubitemid 43726897)
31. J. Creaney, D. Yeoman, L. Naumoff, M. Hof, A. Segal, and A. Musk Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma Thorax 62 2007 569 576 (Pubitemid 47056881)
32. SPSS for Windows. Release 6.0. Chicago, IL: SPSS Inc.1993.
33. R.W. Light Pleural diseases 5th ed 2007 Lippincott. Williams & Wilkins Philadelphia
34. V. Villena, A. López, J. Echave-Sustaeta, C. Álvarez, and P. Martín Estudio prospectivo de 1000 pacientes consecutivos con derrame pleural. Etiología del derrame pleural y carácterísticas de los pacientes Arch Bronconeumol 38 2002 21 26
35. T. Bartter, R. Santarelli, S.M. Akers, and M.R. Pratter The evaluation of pleural effusion Chest 106 1994 1209 1214 (Pubitemid 24309564)
36. R.W. Light Pleural effusion N Engl J Med 346 2002 1971 1977 (Pubitemid 34651358)
37. A.A. El Solh, T. Abdo, L. Pineda, F. Ramadan, and E. Berbary A longitudinal study of idiopathic exudative lymphocytic pleural efusión in older people J Am Geriatr Soc 53 2005 1957 1960 (Pubitemid 41826074)
38. J.M. Porcel, and M. Rubio Evaluación diagnóstica del derrame pleural Med Clin (BARC) 123 2004 426 432
39. Y.C. Gary Lee Hunting for a pleural fluid test for mesothelioma: is soluble mesothelin the answer? Thorax 62 2007 561 562